Quay Pharma services

We are fully equipped and accredited to manufacture a wide range of products for Phase 2 and small-scale Phase 3 trials. We provide this service to pharmaceutical and biopharmaceutical clients throughout the world.

Quay Pharma is widely recognised as leading experts in all aspects of pharmaceutical development and dosage form optimisation for a wide range of product types, including those that have poor solubility or bioavailability.

We are extensively involved in developing early clinical formulations and clinical manufacturing of First in Human trials. We can develop a formulation specifically designed to achieve your targets during the crucial first clinical evaluations of your API.

Quay Pharma has successfully updated its license with the MHRA to include commercial manufacture.